Article

Article

Commanders & Chiefs: Clinical Services C-Suite – Pharmavoice

February 2, 2021
Article

Statistical Considerations for Trials in Adjuvant Treatment of Colorectal Cancer

November 25, 2020
Article

2021 Year in Preview: The Year to Come and the Year That Was

November 17, 2020
Article

Epidemiology, Methodology, and Clinical Research in the midst of the COVID-19 pandemic

November 2, 2020
Article

Evaluating the Potential of Relapse-Free Survival as a Surrogate for Overall Survival in the Adjuvant Therapy of Melanoma with Checkpoint Inhibitors

August 10, 2020
Article

IDDI Published an Editorial on Non-Inferiority Trials

August 5, 2020
Article

Assessing Treatment Benefit in Immuno-oncology

June 9, 2020
Article

Statistical Aspects in Adjuvant and Neoadjuvant Trials for Gastrointestinal Cancer in 2020: Focus on Time-To-Event Endpoints

June 8, 2020
Article

Finding the one: How to choose a Clinical Partner in Sea of Service Providers

June 8, 2020
Article

Integration of Biomarker Validation in Clinical Development in Oncology

June 2, 2020

When every data point represents a patient, accuracy and integrity aren’t optional — they’re everything. That’s why it’s IDDI.

Start Now